North Carolina Marijuana Business Licenses
Status: In North Carolina, qualifying patients can possess and use CBD products. The state does not have or allow a regulated system for cultivation, production, or dispensing of the CBD products.
CBD Program | Medical Program | Recreational Program | Are Applications Open? |
Legal | Not legal | Not legal | closed |
__________
Download Here
__________
Provide Capital
__________
View Plans
Number of North Carolina Marijuana Business Licenses Licenses Available
Dispensaries | Cultivation | Manufacturing/Processing | Transportation |
0 | 0 | 0 | 0 |
You can read the full text of the North Carolina Marijuana Business Licenses law at: www.ncleg.net
North Carolina Medical Marijuana License Guidelines
The state does not have or allow a regulated system for cultivation, production, or dispensing of the CBD products. A neurologist must be affiliated with an in-state licensed hospital to obtain the medicine. Therefore, the state of North Carolina currently is not accepting applications for marijuana businesses. To get ahead of the game and prepare for your marijuana business, review the resources below.
RECOMMENDED NORTH CAROLINA MARIJUANA BUSINESS PLANS FOR MARIJUANA BUSINESS APPLICATION:
- Marijuana Business Plan Package
- Business & Operations Plan Template
- Cultivation Plan Template
- Manufacturing/Processing Plan Template
- Environmental Plan Template
- Financial Plan Template
- Fire Safety Plan Template
- Inventory Control Plan Template
- Patient Education Plan Template
- Patient Recordkeeping Plan Template
- Product Safety Plan Template
- Security Plan Template
- Staffing Plan Template
- Suitability of Proposed Facility Plan Template
- Transportation Plan Template
The History of North Carolina Marijuana Business Licenses Marijuana
In 2014, North Carolina legalized a limited medical marijuana program through legislation. The law, known as the North Carolina Epilepsy Alternative Treatment Act, allows for qualifying patients to use and possess low THC and high CBD extracts. The law was amended in July 2015 so that qualifying patients no longer had to participate in a pilot study to receive treatment. Under the law, patients must have intractable epilepsy and be under the care of a state-approved neurologist who has attempted at least three other treatments options with no benefit. The neurologist must be affiliated with an in-state licensed hospital to obtain the medicine as personal cultivation and a statewide regulated dispensary system is not allowed.